- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/31 - Somatostatins
Patent holdings for IPC class A61K 38/31
Total number of patents in this class: 292
10-year publication summary
|
32
|
20
|
24
|
25
|
24
|
29
|
19
|
22
|
18
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Camurus AB | 148 |
21 |
| Novartis AG | 10338 |
20 |
| Amryt Pharmaceuticals, Inc. | 73 |
14 |
| Ipsen Pharma S.A.S. | 375 |
9 |
| Salix Pharmaceuticals, Inc. | 83 |
7 |
| BCN Peptides, S.A. | 31 |
6 |
| Mondobiotech Laboratories AG | 311 |
6 |
| Otsuka Pharmaceutical Co., Ltd. | 1504 |
6 |
| The Scripps Research Institute | 1343 |
6 |
| Rani Therapeutics, LLC | 193 |
5 |
| Amryt Endo, Inc. | 29 |
5 |
| Mayo Foundation for Medical Education and Research | 3354 |
4 |
| Glytech, Inc. | 62 |
4 |
| Recordati AG | 39 |
4 |
| Nbo Pharma Inc. | 4 |
4 |
| Amryt Endo, Inc. | 5 |
4 |
| Evonik Corporation | 79 |
3 |
| Antisense Therapeutics Ltd. | 26 |
3 |
| Debiopharm International SA | 135 |
3 |
| Italfarmaco SpA | 155 |
3 |
| Other owners | 155 |